#BrainFood 06.18.24
Get ready for a flood of AI Avatars- aka videos that look like real, but are completely generated.
What is Symphony Avatars?
Symphony Avatars is a new AI tool from TikTok that allows creators and brands to generate digital avatars for use in branded content.
How do Symphony Avatars work?
The avatars are generated using generative AI technology. They can display a wide variety of gestures, expressions, nationalities, ages and languages. Creators can leverage their own likeness to construct multi-lingual avatars to expand global reach and brand collaborations. Brands can build avatars with their own IP, spokespeople or partner creators.
What is the goal of Symphony Avatars?
The goal is to help creators and brands captivate global audiences and deliver impactful branded messages in an authentic, immersive way. By using realistic digital avatars, they can scale creative strategies and localize global campaigns more easily. TikTok sees this as fueling the creator economy by enabling new creative solutions.
Color Health Transforms Cancer Care with ChatGPT
What is Color Health?
Color Health is a healthcare company that uses OpenAI's GPT-4o language model to help doctors create personalized cancer treatment plans. The AI system analyzes patient data, clinical guidelines, and other information to identify missing diagnostics and generate tailored workup plans.
How does Color Health's AI system work?
The AI system extracts and processes patient information like family history and risk factors, along with clinical data from trusted sources. It then answers key questions like "What screenings should the patient be doing?" to generate a personalized screening plan. A clinician reviews and can modify the AI's output before presenting it to the patient.
What is the impact of Color Health's AI system?
By streamlining the process of creating comprehensive treatment plans, Color Health aims to reduce delays in cancer treatment, which can significantly impact patient outcomes. The company is partnering with UCSF to evaluate the tool and potentially integrate it into clinical workflows for all new cancer cases.